We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A blue beetle.

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Protein structures.

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

Two hands holding up a nasal spray, a packet of white pills and a tissue.

Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections

Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

News

Malvern to Acquire MicroCal Business from GE

Malvern Instruments has entered into an agreement with GE Healthcare Life Sciences to acquire the company’s MicroCal™ microcalorimetry business.

B-MS, Syngene Extend Research Collaboration

Companies announce a five-year extension of their drug discovery and development collaboration in India.

Merck’s Melanoma Drug Shows Overall Survival Rate of 69%

Pembrolizumab as monotherapy shows estimated overall survival rate at one year across 411 advanced melanoma patients with varying stages of disease and prior therapy.

Arena Initiates Phase 1b Trial for Autoimmune Disease Drug

Trial will evaluate safety, tolerability and pharmacokinetics of APD334 for treatment of a number of autoimmune diseases.

AMRI to Acquire Oso Biopharmaceuticals Manufacturing

Acquisition significantly expands contract manufacturing capabilities to include commercial scale sterile injectables.

Determining Charge and Diffusion Interaction Parameter

New study from Wyatt Technology showcases developments in the ability to characterize colloidal stability to establish suitability of protein formulations for drug therapeutics.

DefiniGEN Announces Closing of £2.3 million ($3.8 million) Series A Fundraising

Funding will be used to launch new stem cell products for drug discovery and regenerative medicine.

Provence Technologies Acquires Synprosis

The acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic chemistry.

PharmaCell to Finalize Purchase of Cell Therapy Production Facility

The purchase includes qualified employees bringing many years of experience in cell therapy manufacturing.

Horizon Completes Acquisition of CombinatoRx from Zalicus

Acquisition of revenue generating and complementary business establishes Horizon’s headquarters in North America.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter